It does not look super low-profile but is still confidence-inspiring. I tested the 15-degree 3 wood and the 21-degree 7 wood with a Mitsubishi Chemical AV series 65 S-Flex shaft in both. I tested this ...
TOKYO -- Japan's Mitsubishi Chemical Group announced on Friday the agreed sale of its pharmaceutical subsidiary, Mitsubishi Tanabe Pharma, to U.S. investment fund Bain Capital for approximately ...
Tokyo, Feb. 7 (Jiji Press)--Mitsubishi Chemical Group Corp. said Friday that it will sell subsidiary Mitsubishi Tanabe Pharma Corp. to U.S. investment firm Bain Capital LP. for about 510 billion yen.
TOKYO : Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity firm Bain Capital in a deal worth 510 billion yen ($3.36 billion ...
TOKYO : Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical subsidiary Tanabe Mitsubishi Pharma to U.S. private equity firm Bain Capital in a deal worth 510 billion yen ($3.36 ...
The U.S. investment company said Friday that it will buy Mitsubishi Tanabe Pharma for about 510 billion yen, equivalent to $3.37 billion.
BEND, Ore., February 03, 2025--(BUSINESS WIRE)--Mitsubishi Gas Chemical Company, Inc. (MGC), a Japanese methanol manufacturer and supplier for chemical and energy sectors including Methanol-to ...
is the pharmaceutical division of Mitsubishi Chemical Group. Under deal terms announced Friday, this pharma unit, which traces its origins to a Japanese business started in 1638, will split off ...
Private equity firm Bain Capital agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit, adding to a dealmaking boom in Japan. The deal values Mitsubishi Tanabe Pharma at about ¥510 ...
Private equity firm Bain Capital agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit, adding to a dealmaking boom in Japan. The deal values Mitsubishi Tanabe Pharma at about 510 billion ...
TOKYO/HONG KONG, Jan 21 (Reuters) - Japan's Mitsubishi Chemical Group (4188.T), opens new tab has picked U.S. investment fund Bain Capital as the preferred bidder for its pharmaceutical subsidiary ...
TOKYO -- Japan's Mitsubishi Chemical Group has granted a first-refusal right to U.S. investment fund Bain Capital for the purchase of its pharmaceutical subsidiary Mitsubishi Tanabe Pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback